Genscript Biotech plans spin-off and Hong Kong listing of Probio
Genscript Biotech plans a spin-off and a Hong Kong listing of its non-wholly-owned subsidiary Probio Technology.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Genscript Biotech plans a spin-off and a Hong Kong listing of its non-wholly-owned subsidiary Probio Technology.